Pra Health Sciences Cri Lifetree Division
Research, 4131 Parklake Ave, NJ, North Carolina, 27612, United States, 5001-10000 Employees
Who is PRA HEALTH SCIENCES - CRI LIFETREE DIVISION
Starting over 18 months ago, PRA strategically strengthened its coverage of China and created a joint venture with the leading clinical development firm in China, forming WuXiPRA. PRA the...
Read More
-
Headquarters: 4131 Parklake Ave, NJ, North Carolina, 27612, United States
-
Date Founded: 2000
-
Employees: 5001-10000
-
Revenue: $1 Billion and Over
-
Active Tech Stack: See technologies
SIC Code: 
Does something look wrong? Fix it. | View contact records from PRA HEALTH SCIENCES - CRI LIFETREE DIVISION
PRA Health Sciences - CRI Lifetree Division Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding PRA Health Sciences - CRI Lifetree Division
Answer: PRA Health Sciences - CRI Lifetree Division's headquarters are located at 4131 Parklake Ave, NJ, North Carolina, 27612, United States
Answer: PRA Health Sciences - CRI Lifetree Division's official website is https://crilifetree.com
Answer: PRA Health Sciences - CRI Lifetree Division's revenue is $1 Billion and Over
Answer: PRA Health Sciences - CRI Lifetree Division's SIC: 8731
Answer: PRA Health Sciences - CRI Lifetree Division's NAICS: 541715
Answer: PRA Health Sciences - CRI Lifetree Division has 5001-10000 employees
Answer: PRA Health Sciences - CRI Lifetree Division is in Research
Answer: PRA Health Sciences - CRI Lifetree Division contact info: Phone number: Website: https://crilifetree.com
Answer: Starting over 18 months ago, PRA strategically strengthened its coverage of China and created a joint venture with the leading clinical development firm in China, forming WuXiPRA. PRA then bolstered its capabilities in Russia and Eastern Europe by acquiring ClinStar, the premier provider of CRO services in Russia and Eastern Europe. With the subsequent acquisition of RPS, the pioneer of the Embedded Solutions™ model, PRA enhanced its ability to offer a more comprehensive breadth of services across all segments of the biopharmaceutical industry. At the close of 2013, PRA purchased CRI Lifetree, which augmented its existing Phase I and bioanalytical capabilities, cementing PRA as the most comprehensive, high-end Phase I organization in the world. “The expansion of our global presence, the growth in our breadth of services, and the deepening of our capabilities we initiated over the last year-and-a-half enable us to better serve our clients,” said Colin Shannon, president and CEO, PRA Health Sciences. “This change to our name reflects our historical roots as a scientifically rich company, the breadth and depth of our solutions, and most importantly, our dedication to working with sponsors to bring new treatments to market that will positively impact the lives of patients and their families.” As one unified company with a broad range of specific expertise, PRA is well-equipped and intently focused on working to improve the lives of patients and providing innovative solutions that will drive the future of clinical development.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month